Panacea Biotec Limited has announced the receipt of an additional award from UNICEF for the supply of 40 million doses (2 million vials) of its bivalent oral polio vaccine (bOPV). This new order is valued at approximately US$ 5.20 million (~₹44 crore) and will be executed in the third quarter of calendar year 2025.
This follows the earlier order secured in December 2024 for 115 million doses worth US$ 14.95 million. Panacea Biotec’s Long Term Arrangement with UNICEF will be amended to incorporate this latest award. This milestone further strengthens Panacea’s role in global immunization efforts.
